Measurement Variability in Treatment Response Determination for Non–Small Cell Lung Cancer
Authors:
- 1 March 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Thoracic Imaging
- Vol. 34 (2) , 103-115
Abstract
Multimodality imaging measurements of treatment response are critical for clinical practice, oncology trials, and the evaluation of new treatment modalities. The current standard for determining treatment response in non–small cell lung cancer (NSCLC) is based on tumor size using the RECIST criteria. Molecular targeted agents and immunotherapies often cause morphological change without reduction of tumor size. Therefore, it is difficult to evaluate therapeutic response by conventional methods. Radiomics is the study of cancer imaging features that are extracted using machine learning and other semantic features. This method can provide comprehensive information on tumor phenotypes and can be used to assess therapeutic response in this new age of immunotherapy. Delta radiomics, which evaluates the longitudinal changes in radiomics features, shows potential in gauging treatment response in NSCLC. It is well known that quantitative measurement methods may be subject to substantial variability due to differences in technical factors and require standardization. In this review, we describe measurement variability in the evaluation of NSCLC and the emerging role of radiomics.Keywords
This publication has 90 references indexed in Scilit:
- Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- CT Tumor Volume Measurement in Advanced Non-small-cell Lung CancerAcademic Radiology, 2011
- Positron Emission Tomography-Computed Tomography Standardized Uptake Values in Clinical Practice and Assessing Response to TherapySeminars in Ultrasound, CT and MRI, 2010
- A Pilot Study of Volume Measurement as a Method of Tumor Response Evaluation to Aid Biomarker DevelopmentClinical Cancer Research, 2010
- Predicting and monitoring cancer treatment response with diffusion‐weighted MRIJournal of Magnetic Resonance Imaging, 2010
- Lung nodule volumetry: segmentation algorithms within the same software package cannot be used interchangeablyEuropean Radiology, 2010
- Volumetric measurement of pulmonary nodules at low-dose chest CT: effect of reconstruction setting on measurement variabilityEuropean Radiology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Scan‐rescan variability in perfusion assessment of tumors in MRI using both model and data‐derived arterial input functionsJournal of Magnetic Resonance Imaging, 2008
- A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imagingBritish Journal of Cancer, 2006